472 related articles for article (PubMed ID: 27374332)
1. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Denny SK; Yang D; Chuang CH; Brady JJ; Lim JS; Grüner BM; Chiou SH; Schep AN; Baral J; Hamard C; Antoine M; Wislez M; Kong CS; Connolly AJ; Park KS; Sage J; Greenleaf WJ; Winslow MM
Cell; 2016 Jul; 166(2):328-342. PubMed ID: 27374332
[TBL] [Abstract][Full Text] [Related]
2. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
[TBL] [Abstract][Full Text] [Related]
3. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
4. Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.
Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
[TBL] [Abstract][Full Text] [Related]
5. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
[TBL] [Abstract][Full Text] [Related]
6. Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin.
Yang D; Denny SK; Greenside PG; Chaikovsky AC; Brady JJ; Ouadah Y; Granja JM; Jahchan NS; Lim JS; Kwok S; Kong CS; Berghoff AS; Schmitt A; Reinhardt HC; Park KS; Preusser M; Kundaje A; Greenleaf WJ; Sage J; Winslow MM
Cancer Discov; 2018 Oct; 8(10):1316-1331. PubMed ID: 30228179
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor I/B is an oncogene in small cell lung cancer.
Dooley AL; Winslow MM; Chiang DY; Banerji S; Stransky N; Dayton TL; Snyder EL; Senna S; Whittaker CA; Bronson RT; Crowley D; Barretina J; Garraway L; Meyerson M; Jacks T
Genes Dev; 2011 Jul; 25(14):1470-5. PubMed ID: 21764851
[TBL] [Abstract][Full Text] [Related]
8. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.
Gao G; Hausmann S; Flores NM; Benitez AM; Shen J; Yang X; Person MD; Gayatri S; Cheng D; Lu Y; Liu B; Mazur PK; Bedford MT
Nat Commun; 2023 Jan; 14(1):363. PubMed ID: 36690626
[TBL] [Abstract][Full Text] [Related]
9. Opening a Chromatin Gate to Metastasis.
Minna JD; Johnson JE
Cell; 2016 Jul; 166(2):275-276. PubMed ID: 27419866
[TBL] [Abstract][Full Text] [Related]
10. ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.
Szczepanski AP; Zhao Z; Sosnowski T; Goo YA; Bartom ET; Wang L
Genome Med; 2020 Jul; 12(1):63. PubMed ID: 32669118
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of small cell lung cancer metastasis.
Ko J; Winslow MM; Sage J
EMBO Mol Med; 2021 Jan; 13(1):e13122. PubMed ID: 33296145
[TBL] [Abstract][Full Text] [Related]
12. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
[TBL] [Abstract][Full Text] [Related]
13. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ
Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878
[TBL] [Abstract][Full Text] [Related]
14. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
15. miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
Sun L; Fang Y; Wang X; Han Y; Du F; Li C; Hu H; Liu H; Liu Q; Wang J; Liang J; Chen P; Yang H; Nie Y; Wu K; Fan D; Coffey RJ; Lu Y; Zhao X; Wang X
Theranostics; 2019; 9(26):8409-8425. PubMed ID: 31754405
[No Abstract] [Full Text] [Related]
16. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.
McFadden DG; Papagiannakopoulos T; Taylor-Weiner A; Stewart C; Carter SL; Cibulskis K; Bhutkar A; McKenna A; Dooley A; Vernon A; Sougnez C; Malstrom S; Heimann M; Park J; Chen F; Farago AF; Dayton T; Shefler E; Gabriel S; Getz G; Jacks T
Cell; 2014 Mar; 156(6):1298-1311. PubMed ID: 24630729
[TBL] [Abstract][Full Text] [Related]
17. Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Becker-Santos DD; Thu KL; English JC; Pikor LA; Martinez VD; Zhang M; Vucic EA; Luk MT; Carraro A; Korbelik J; Piga D; Lhomme NM; Tsay MJ; Yee J; MacAulay CE; Lam S; Lockwood WW; Robinson WP; Jurisica I; Lam WL
J Pathol; 2016 Oct; 240(2):161-72. PubMed ID: 27357447
[TBL] [Abstract][Full Text] [Related]
18. A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.
Mirabello L; Koster R; Moriarity BS; Spector LG; Meltzer PS; Gary J; Machiela MJ; Pankratz N; Panagiotou OA; Largaespada D; Wang Z; Gastier-Foster JM; Gorlick R; Khanna C; de Toledo SR; Petrilli AS; Patiño-Garcia A; Sierrasesúmaga L; Lecanda F; Andrulis IL; Wunder JS; Gokgoz N; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Halai D; Ballinger ML; Thomas DM; Davis S; Barkauskas DA; Marina N; Helman L; Otto GM; Becklin KL; Wolf NK; Weg MT; Tucker M; Wacholder S; Fraumeni JF; Caporaso NE; Boland JF; Hicks BD; Vogt A; Burdett L; Yeager M; Hoover RN; Chanock SJ; Savage SA
Cancer Discov; 2015 Sep; 5(9):920-31. PubMed ID: 26084801
[TBL] [Abstract][Full Text] [Related]
19. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
[TBL] [Abstract][Full Text] [Related]
20. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]